Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Chiara Verra
Institutions:
Queen Mary University of London,
Joint Research Centre,
William Harvey Research Institute
Observed institutions:
Queen Mary University of London,
Joint Research Centre,
William Harvey Research Institute
ORCID:
0009-0002-1601-301X
Observed ORCID:
0009-0002-1601-301X
OpenAlex ID:
A5000603265
RG100204, A Novel Aquaporin-9 Inhibitor, Reduces Septic Cardiomyopathy and Multiple Organ Failure in Murine Sepsis
2022
·
Shireen Mohammad
, Caroline E. O’Riordan
, et al.
·
Frontiers in Immunology
·
43
PDF
Total organic carbon (TOC): a simple tool for assessing micro(nano)plastics and nanocellulose recovery during size-based fractionation
2025
·
Guillaume Bucher
, Gabriella F. Schirinzi
, et al.
·
Analytical and Bioanalytical Chemistry
·
14
PDF
Spleen tyrosine kinase: a novel pharmacological target for sepsis-induced cardiac dysfunction and multi-organ failure
2024
·
Chiara Verra
, Maria Kerstin Paulmann
, et al.
·
Frontiers in Immunology
·
11
PDF
RETRACTED: Baricitinib protects mice from sepsis-induced cardiac dysfunction and multiple-organ failure
2023
·
Chiara Verra
, Shireen Mohammad
, et al.
·
Frontiers in Immunology
·
10
PDF
Characterisation of Nanocellulose Types Using Complementary Techniques and Its Application to Detecting Bacterial Nanocellulose in Food Products
2025
·
Otmar Geiss
, Ivana Bianchi
, et al.
·
Nanomaterials
·
3
PDF
Correction: RG100204, a novel Aquaporin-9 inhibitor, reduces septic cardiomyopathy and multiple organ failure in murine sepsis
2025
·
Shireen Mohammad
, Caroline E. O’Riordan
, et al.
·
Frontiers in Immunology
·
1
PDF
Show more works
View as search
Works count:
6
Citation count:
82
H-index:
4
I10-index:
4
Year
Topic
Type